Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
How Supply & Demand is Likely Driving the Uranium Market to Reach a 16-Year Peak This Year
-
BNP Paribas Exane Grows Global Team with Five Senior US Analyst Appointments
-
How Supply & Demand is Likely Driving the Uranium Market to Reach a 16-Year Peak This Year
-
FREE Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Whole Earth Brands to Entities Affiliated With its Largest Shareholder
-
FREE Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Whole Earth Brands to Entities Affiliated With its Largest Shareholder
-
Form 8.3 - [KIN & CARTA PLC] - 12 02 2024 (CGAML)
-
Form 8.3 - [ LXi REIT PLC] - 12 02 2024 - (CGWL)
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC] - 12 02 2024 - (CGWL)
-
Canada Rich in Uranium Resources Projected to Fuel Strong Growth for Mining Industry Over Next Five Years
-
Final Prospectus Filed-Books Closing February 22, 2024 for Initial Closing
-
Onkos Surgical Presents at the Canaccord Genuity 2024 Musculoskeletal Healthcare Conference
-
RETRANSMISSION: HIVE Digital Announces Quarterly Revenue of $31.3 Million with a Gross Operating Margin of $11.3 Million and Production of 830 Bitcoin
-
HIVE Digital Technologies (HIVE) Reports Q3 Revenue of $30.1M, Net Loss of $6.95M
-
HIVE Digital Announces Quarterly Revenue of $31.3 Million with a Gross Operating Margin of $11.3 Million and Production of 830 Bitcoin
-
Monogram Orthopaedics to Present Rescheduled Product Discussion with Surgeon Reaction during AAOS Annual Meeting
-
Newell Rubbermaid (NWL) PT Lowered to $9 at Canaccord Genuity on 'underwhelming guidance'
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 09 02 2024] - (CGWL)
-
Form 8.3 - [SMART METERING PLC - 09 02 2024] - (CGWL)
-
Form 8.3 - [LXi REIT PLC - 09 02 2024) - (CGWL)
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 09 02 2024] - (CGWL)
-
OnPoint to participate in the 2024 Canaccord Genuity Musculoskeletal Conference
-
Spire Global (SPIR) PT Lowered to $25 at Canaccord Genuity
-
TD Securities Upgrades Canaccord Genuity Group (CF:CN) (CCORF) to Buy
-
MedBright AI Announces Closing of LIFE Offering for Gross Proceeds of Approximately $1.4 Million
-
IsoEnergy Completes C$23 Million Bought Deal Private Placement
-
Canaccord Genuity Upgrades Sangoma Technologies Corp (SANG) to Spec. Buy, 'Market is Already Pricing in a Recovery'
-
URANIUM ROYALTY ANNOUNCES CLOSING OF BOUGHT DEAL FINANCING
-
Caira Surgical to Present Innovative Radar Surgical Tracking at CG 2024 Musculoskeletal Conference
-
Canaccord Genuity Downgrades Spectrum Brands (SPB) to Hold, 'Better Q1, but the market is already pricing in a recovery'
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 08 02 2024] - (CGWL)
-
Form 8.3 - [SMART METERING PLC - 08 02 2024] - (CGWL)
-
Form 8.3 - [LXi REIT PLC - 08 02 2024) - (CGWL)
-
Form 8.3 - [abrdn EUROPEAN LOGISTICS INCOME PLC - 08 02 2024] - (CGWL)
-
Metals Acquisition Limited Initial Offering in Connection with ASX Listing Oversubscribed and Upsized to ~A$325million
-
Correction: Interim Management Statement
-
Interim Management Statement
-
Interim Management Statement Q1 2024
-
Lion One Announces Terms of Upsized Fully Subscribed C$10.5 Million Offering
-
Alaska Energy Metals Announces Closing of $1 Million Special Warrant Offering
-
Stallion Uranium Announces Closing of Listed Issuer Financing Exemption (LIFE) Non-Brokered Private Placement
-
DiscGenics to Present at Canaccord Genuity 2024 Musculoskeletal Conference
-
Form 8.3 - [CITY PUB GROUP PLC - 07 02 2024] - (CGAML)
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 07 02 2024] - (CGWL)
-
Form 8.3 - [SMART METERING PLC - 07 02 2024] - (CGWL)
-
Form 8.3 - [LXi REIT PLC - 07 02 2024) - (CGWL)
-
Capstone Copper and Orion Announce Closing of C$431 Million Bought Deal
-
Biora Therapeutics Announces Participation in Canaccord Genuity Inflammatory Bowel Disease Symposium
-
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
-
Form 8.3 - [YOUNG & CO.'S BREWERY PLC 06 02 2024] - (CGWL)
-
Form 8.3 - [SMART METERING PLC - 06 02 2024] - (CGWL)

